In vitro comparison of A-56619, A-56620, amifloxacin, ciprofloxacin, enoxacin, norfloxacin, and ofloxacin against methicillin-resistant Staphylococcus aureus
- 1 February 1986
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 29 (2) , 325-326
- https://doi.org/10.1128/aac.29.2.325
Abstract
Seven quinolone antibiotics were tested against 115 isolates of methicillin-resistant Staphylococcus aureus. The MICs for 90% of the strains tested were 0.5 microgram/ml for A-56619, A-56620, ciprofloxacin, and ofloxacin; 2.0 micrograms/ml for amifloxacin and enoxacin; and 4.0 micrograms/ml for norfloxacin. Killing kinetic studies showed a similar killing rate for all seven antibiotics.This publication has 14 references indexed in Scilit:
- Open, prospective study of the clinical efficacy of ciprofloxacinAntimicrobial Agents and Chemotherapy, 1985
- Enoxacin compared with cefoperazone for the treatment of experimental Enterobacter aerogenes endocarditisAntimicrobial Agents and Chemotherapy, 1985
- Activity of ciprofloxacin against methicillin-resistant Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 1985
- Pefloxacin therapy for experimental endocarditis caused by methicillin-susceptible or methicillin-resistant strains of Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 1985
- Norfloxacin versus trimethoprim-sulfamethoxazole in the therapy of uncomplicated, community-acquired urinary tract infectionsAntimicrobial Agents and Chemotherapy, 1985
- Antimicrobial spectrum of Win 49375Antimicrobial Agents and Chemotherapy, 1984
- In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprimAntimicrobial Agents and Chemotherapy, 1983
- In vitro antibacterial properties of AT-2266, a new pyridonecarboxylic acidAntimicrobial Agents and Chemotherapy, 1983
- In vitro activity of ciprofloxacin, norfloxacin and nalidixic acidEuropean Journal of Clinical Microbiology & Infectious Diseases, 1983
- In vitro and in vivo activity of DL-8280, a new oxazine derivativeAntimicrobial Agents and Chemotherapy, 1982